<DOC>
	<DOCNO>NCT00187278</DOCNO>
	<brief_summary>The primary purpose study evaluate patient standard indication permanent ventricular pacing , leave ventricular ejection fraction without limit , QRS duration profit prevention ventricular desynchronisation .</brief_summary>
	<brief_title>Biopace Study : Biventricular Pacing Atrioventricular Block Prevent Cardiac Desynchronization</brief_title>
	<detailed_description>The study perform control , single-blind , international , multicenter , prospective , randomize , parallel group design . In order pragmatically examine effectiveness biventricular pacing patient indication ventricular pacing , study group biventricular pace compare control group standard pacemaker allow univentricular ( right ventricular ) stimulation , standard outside clinical study far .</detailed_description>
	<mesh_term>Ventricular Dysfunction</mesh_term>
	<mesh_term>Atrioventricular Block</mesh_term>
	<criteria>Presence indication ventricular pace accord actual guideline implantation cardiac pacemaker need frequent ( even permanent ) ventricular pacing : Permanent 3rd degree atrioventricular ( AV ) block Intermittent 3rd degree AVblock combination 1st degree AVblock pQinterval ≥ 220 m 2nd degree AVblock type Mobitz II combination 1st degree AVblock pQinterval ≥ 220 m 2nd degree AVblock type Mobitz I ( indicate ) combination 1st degree AVblock pQinterval ≥ 220 m 1st degree AVblock pQinterval ≥ 220 ms indication ventricular pacing ( include indication ventricular pace base long HV interval measure invasive electrophysiological testing ) Sicksinussyndrome symptomatic sinus bradycardia sinus arrest primary indication device implantation combination long 1st degree AVblock pQinterval ≥ 220 m Chronic ( permanent ) atrial fibrillation ( flutter tachycardia ) spontaneous heart ( ventricular ) rate rest ≤ 60/min Chronic ( permanent ) atrial fibrillation ( flutter tachycardia ) spontaneous heart ( ventricular ) rate rest ≤ 75/min , initiation increase pharmacological treatment relevant heart rate lower effect ( negative chronotropic effect ) plan time pacemaker implantation ( i.e . ßblockers heart failure rate control ) Patients schedule AV node ablation Any QRS duration morphology Left ventricular ejection fraction ( LVEF ) without limit measure echocardiography ( least one plane , either 4 2chamber apical long axis view ) Signed write informed consent patient firstdegree relative study participation inform patient/relative risk aim study Willingness ability comply prescribe followup test schedule evaluation . Absence implant ventricular pacing device ( patient atrial pacemaker new need ventricular pacing may include ) Implanted Cardioverter Defibrillator consideration implantation ICD due arrhythmia indication . However , ICD implant primary prevention sudden cardiac death patient LVEF ≤ 35 % ( accordance actual guideline implantation arrhythmia device [ LVEF &lt; 30 % ] accordance result SCDHeft study [ LVEF &lt; 35 % ) allow . Implanted ventricular pace device Status 1 cardiac transplantation likelihood receive transplantation within 2 year ( patient would expect fulfill followup requirement outline protocol ) Evidence acute leave ventricular dysfunction high probability reversibility ( e.g . acute myocarditis , tachycardiomyopathy ) Implanted prosthetic tricuspid valve Severe musculoskeletal disorder ( ) Age 18 year Current plan pregnancy next 6 month Current recent ( within past 30 day ) participation clinical investigation Life expectancy le 6 month Patient 's inability independently comprehend complete Quality Life ( QoL ) questionnaire</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Standard pace indication</keyword>
</DOC>